Owens & Minor, Inc. (OMI)
| Market Cap | 411.71M |
| Revenue (ttm) | 10.76B |
| Net Income (ttm) | -1.20B |
| Shares Out | 77.24M |
| EPS (ttm) | -15.63 |
| PE Ratio | n/a |
| Forward PE | 6.26 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,781,761 |
| Open | 5.57 |
| Previous Close | 5.47 |
| Day's Range | 5.25 - 5.70 |
| 52-Week Range | 4.56 - 16.63 |
| Beta | 1.03 |
| Analysts | Hold |
| Price Target | 9.68 (+81.61%) |
| Earnings Date | Aug 11, 2025 |
About OMI
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management... [Read more]
Financial Performance
In 2024, Owens & Minor's revenue was $10.70 billion, an increase of 3.55% compared to the previous year's $10.33 billion. Losses were -$362.69 million, 778.2% more than in 2023.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for OMI stock is "Hold." The 12-month stock price target is $9.68, which is an increase of 81.61% from the latest price.
News
Owens & Minor Analysts Boost Their Forecasts After Q2 Results
Owens & Minor, Inc. OMI reported worse-than-expected second-quarter earnings on Monday.
Owens & Minor: An Extreme Reached Amid Disastrous Results (Rating Upgrade)
Owens & Minor, Inc.'s disastrous performance, weak margins, and strategic missteps have eroded investor confidence and driven OMI stock down 70% in a year. The planned sale of its core Products & Heal...
Owens & Minor, Inc. (OMI) Q2 2025 Earnings Call Transcript
Owens & Minor, Inc. (NYSE:OMI) Q2 2025 Earnings Conference Call August 11, 2025 8:30 AM ET Company Participants Jacqueline Marcus - IR, Alpha IR Group LLC Edward A. Pesicka - President, CEO & Directo...
US Stocks Mixed; Owens & Minor Posts Downbeat Earnings
U.S. stocks traded mixed this morning, with the Nasdaq Composite declining around 0.2% on Monday.
Owens & Minor Reports Second Quarter 2025 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products ...
Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings
Owens & Minor, Inc. OMI will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.
Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2025 on Monday, August 11, 2025, before trading begins on the New York Stoc...
Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced it has mutually agreed with Rotech Healthcare Holdings Inc. to terminate the previously announced acquisition. Under the...
Owens & Minor: FTC Approval And Stock Repurchases Could Trigger The Stock Price
OMI is undervalued, with catalysts including FTC approval for the Rotech acquisition and a potential segment sale that could boost cash and reduce net debt. The company's share buybacks at $8.66 and r...
Owens & Minor, Inc. (OMI) Q1 2025 Earnings Call Transcript
Owens & Minor, Inc. (NYSE:OMI) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Jackie Marcus - IR Edward Pesicka - President and CEO Jonathan Leon - CFO Conference Call P...
Why Is Owens & Minor Stock Trading Lower On Thursday?
Owens & Minor Inc. OMI reported first-quarter 2025 adjusted EPS of 23 cents, up from 19 cents a year ago, beating the consensus of 20 cents.
Owens & Minor Reports First Quarter 2025 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2025. “Across the business we continued to see strong execution a...
Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2025 on Thursday, May 8, 2025, before trading begins on the New York Stock E...
Owens & Minor: A Painful Transformation
Owens & Minor, Inc.'s aggressive dealmaking and substantial debt have led to a mixed track record and declining stock performance, raising skepticism about future prospects. The company's acquisition ...
Owens & Minor Announces Major Innovations to Products & Healthcare Services Network
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced important milestones in advancing the medical distribution capabilities of its Products & Healthcare Services (P&HS) bus...
Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today the upsize and pricing of its private offering (the “Offering”) of $1 billion aggregate principal amount ...
Owens & Minor Announces Launch of Senior Secured Notes Offering
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today that it has launched a private offering (the “Offering”) of $600 million aggregate principal amount of se...
Owens & Minor, Inc. (OMI) Q4 2024 Earnings Call Transcript
Owens & Minor, Inc. (NYSE:OMI) Q4 2024 - Earnings Conference Call February 28, 2025 8:30 AM ET Company Participants Jackie Marcus – IR Edward Pesicka - President and CEO Jonathan Leon - CFO Conferenc...
Healthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares
On Monday, Owens & Minor Inc. OMI reported adjusted EPS of $0.45 for the fourth quarter of 2024, down from $0.69 a year ago but beating the consensus of $0.52.
Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2024. “We are pleased with the progress that we have...
Owens & Minor, Inc. (OMI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. ("Owens & Minor" or "the Compan...
Bronstein, Gewirtz & Grossman, LLC Encourages Owens & Minor, Inc. (OMI) Shareholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. ("Owens & Minor" or "the Compan...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Owens & Minor, Inc. (OMI) And Encourages Shareholders to Connect
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. ("Owens & Minor" or "the Compan...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Owens & Minor, Inc. (OMI) And Encourages Shareholders to Reach Out
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. ("Owens & Minor" or "the Compan...
Bronstein, Gewirtz & Grossman, LLC Encourages Owens & Minor, Inc. (OMI) Stockholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. ("Owens & Minor" or "the Compan...